Intravitreal injections service: a patient experience evaluation

Hasan, Hani; Flockhart, Sarah; Qureshi, Waseem; Khan, Selina; Ahmed, Shahina; Shah, Nimish

doi:10.12968/bjon.2017.26.12.678

Cited by 6 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although patients provided highly positive feedback regarding the intravitreal injections performed by nurses, some patients were anxious that the nurse administering injections would be unsafe. 33 The education of patients might reduce these concerns and help them adapt conveniently with the new method of injection. The preferences of patients, for example, the location that the injections are performed, cleanliness of the utilities, waiting time, informed about the procedure, accessibility, and convenience, can also affect patient satisfaction.…”

Section: Discussionmentioning

confidence: 99%

Patient Satisfaction of Intravitreal Bevacizumab Injection Services at a Referral Center

Shayan

Safi

Karimi

et al. 2021

Journal of Current Ophthalmology

View full text Add to dashboard Cite

Purpose:To evaluate the patient satisfaction of intravitreal bevacizumab (IVB) injection services for ocular complications of diabetes mellitus (DM) at a referral center.Methods:Patients with diabetic macular edema (DME) and diabetic retinopathy (DR) who had undergone IVB injections between March and September 2018 were interviewed by telephone using two questionnaires. First, demographic information, medical history, and the Patient Satisfaction Questionnaire Short Form (PSQ-18) 5-point scale were collected. Then, the Retinopathy Treatment Satisfaction Questionnaire (RetTSQ) 7-point scale was completed. Total scores are presented on a 100-point scale, with 100 indicating complete satisfaction.Results:Two hundred and fifty patients (145 with DME and 105 with DR) were interviewed (mean age: 61 ± 10 years; male-to-female ratio: 1:1.5). The response rate was 96%. Twenty-one patients had only one injection. Two hundred and forty-eight (99.2%) patients had insurance. The mean number of total injections was 12.2 ± 11.5. Seventy (28%), forty-seven (18.8%), sixty-one (24.4%), and seventy-two (28.8%) patients underwent IVB treatment for <6 months, between 7 and 12 months, between 13 and 24 months, and >25 months, respectively. The mean total and overall scores were 90.8 ± 22.5 (completely satisfied) and 88.7 ± 16.6 (completely satisfied) based on PSQ-18 and RetTSQ, respectively. Financial problems and appointment scheduling systems were the highest cases of dissatisfaction.Conclusion:The majority of patients were highly satisfied with IVB injections for the management of ocular complications of DM. The appointment taking procedure, waiting times, out-of-pocket expenses, and access to the hospital should be improved.

show abstract

Section: Discussionmentioning

confidence: 99%

Patient Satisfaction of Intravitreal Bevacizumab Injection Services at a Referral Center

Shayan

Safi

Karimi

et al. 2021

Journal of Current Ophthalmology

View full text Add to dashboard Cite

show abstract

“…The department also developed a 12-week training pathway for nurses from induction session to delivering independent intravitreal injection session 13 . Between 2015 and 2020, the number of nurse injectors in the department increased from three to seven while maintaining the standard of injections and keeping patients' satisfaction at a high level 14 . Not only does this up-skill ophthalmic allied health professionals, but leads to a more proficient nurse-led intravitreal injection service and enables more injections to be undertaken.…”

Section: Discussionmentioning

confidence: 99%

Safety and efficacy of nurse led intravitreal injection service with Precivia® injection assist device

Ibrar

Maghsoudlou

Hasan

et al. 2021

European Journal of Ophthalmology

Self Cite

View full text Add to dashboard Cite

Introduction Intravitreal anti-VEGF injections are the most frequently performed outpatient procedure in the UK. Ophthalmic allied healthcare professionals are replacing medical professionals in delivering injections nationwide. The use of injection assist devices such as Precivia® has been well established and increasingly adopted to aid in their safe delivery. We present outcomes of nurse-led intravitreal injections using the Precivia® injection assist device over a five-year period in the UK. Methods A retrospective review was completed of all anti-VEGF intravitreal injections delivered at the Great Western Hospital between May 2015 and May 2020. Results Over the five-year study period, 2318 patients underwent a total of 26,923 intravitreal injections; 20,421 (75.8%) of which were delivered by appropriately trained ophthalmic nurses. The annual number of injections increased year-on-year from 2112 injections in 2015-2016 to 5410 injections in 2019-2020. The mean age of patients was 75.7±12.2 years with a female-to-male ratio was 1.17:1. Wet age-related macular degeneration represented the major indication for injections followed by retinal vein occlusion and diabetic maculopathy respectively. Three cases of post-injection endophthalmitis out of 20,421 (0.015%) injections in nurse injection group were identified during the study period. There were no cases of lens touch, retinal detachment or systemic thromboembolic events. Conclusion Use of the Precivia® intravitreal injection assist device by trained ophthalmic allied health professionals is a safe and cost-effective way to deliver intravitreal injections service.

show abstract

Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): a scoping review

Gomez-Lumbreras,

Ghule,

Panchal

et al. 2023

Int Ophthalmol

View full text Add to dashboard Cite

Intravitreal injections service: a patient experience evaluation

Cited by 6 publications

References 7 publications

Patient Satisfaction of Intravitreal Bevacizumab Injection Services at a Referral Center

Patient Satisfaction of Intravitreal Bevacizumab Injection Services at a Referral Center

Safety and efficacy of nurse led intravitreal injection service with Precivia® injection assist device

Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): a scoping review

Contact Info

Product

Resources

About